AAAAAA

   
Results: 1-17 |
Results: 17
DNA arrays and breast cancer
Authors: Bertucci, F Nguyen, C Houlgatte, R Birnbaum, D
Citation: F. Bertucci et al., DNA arrays and breast cancer, M S-MED SCI, 17(4), 2001, pp. 531-532
Classifying tumors - DNA chips
Authors: Bertucci, F Nguyen, C
Citation: F. Bertucci et C. Nguyen, Classifying tumors - DNA chips, BIOFUTUR, 2001(212), 2001, pp. 42-43
Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: Clinical results and pharmacokinetics
Authors: Goncalves, A Camerlo, J Bun, H Gravis, G Genre, D Bertucci, F Resbeut, M Pech-Gourg, F Durand, A Maraninchi, D Viens, P
Citation: A. Goncalves et al., Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: Clinical results and pharmacokinetics, ANTICANC R, 21(2B), 2001, pp. 1431-1437
DNA arrays: technological aspects and applications
Authors: Bertucci, F Loriod, B Tagett, R Granjeaud, S Birnbaum, D Nguyen, C Houlgatte, R
Citation: F. Bertucci et al., DNA arrays: technological aspects and applications, B CANCER, 88(3), 2001, pp. 243-252
Molecular typing of breast cancer: transcriptomics and DNA microarrays
Authors: Bertucci, F Houlgatte, R Nguyen, C Benziane, A Nasser, V Granjeaud, S Tagett, B Loriod, B Giaconia, A Jacquemier, J Viens, P Birnbaum, D
Citation: F. Bertucci et al., Molecular typing of breast cancer: transcriptomics and DNA microarrays, B CANCER, 88(3), 2001, pp. 277-286
Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin
Authors: Mathoulin-Portier, MP Viens, P Cowen, D Bertucci, F Houvenaeghel, G Geneix, J Puig, B Bardou, VJ Jacquemier, J
Citation: Mp. Mathoulin-portier et al., Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin, ONCOL REP, 7(3), 2000, pp. 675-680
Gene expression profiling of primary breast carcinomas using arrays of candidate genes
Authors: Bertucci, F Houlgatte, R Benziane, A Granjeaud, S Adelaide, J Tagett, R Loriod, B Jacquemier, J Viens, P Jordan, B Birnbaum, D Nguyen, C
Citation: F. Bertucci et al., Gene expression profiling of primary breast carcinomas using arrays of candidate genes, HUM MOL GEN, 9(20), 2000, pp. 2981-2991
Patient participation in medical decision-making: A French study in adjuvant radio-chemotherapy for early breast cancer
Authors: Protiere, C Viens, P Genre, D Cowen, D Camerlo, J Gravis, G Alzieu, C Bertucci, F Resbeut, M Maraninchi, D Moatti, JP
Citation: C. Protiere et al., Patient participation in medical decision-making: A French study in adjuvant radio-chemotherapy for early breast cancer, ANN ONCOL, 11(1), 2000, pp. 39-45
High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advancedovarian carcinoma: long-term results
Authors: Bertucci, F Viens, P Delpero, JR Bardou, VJ Faucher, C Houvenaeghel, G Maraninchi, D
Citation: F. Bertucci et al., High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advancedovarian carcinoma: long-term results, BONE MAR TR, 26(1), 2000, pp. 61-67
Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study
Authors: Genre, D Viens, P Gravis, G Bertucci, F Cowen, D Novakovitch, G Dermeche, S Chabannon, C Oziel-Taieb, S Camerlo, J Houvenaeghel, G Jacquemier, J Maraninchi, D
Citation: D. Genre et al., Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study, ANTICANC R, 20(3B), 2000, pp. 2033-2040
Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples
Authors: Bertucci, F Bernard, K Loriod, B Chang, YC Granjeaud, S Birnbaum, D Nguyen, C Peck, K Jordan, BR
Citation: F. Bertucci et al., Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples, HUM MOL GEN, 8(9), 1999, pp. 1715-1722
Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples (vol 8, pg 1715, 1999)
Authors: Bertucci, F Bernard, K Loriod, B Chang, YC Granjeaud, S Birnbaum, D Nguyen, C Peck, K Jordan, BR
Citation: F. Bertucci et al., Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples (vol 8, pg 1715, 1999), HUM MOL GEN, 8(11), 1999, pp. 2129-2129
Expression scanning of an array of growth control genes in human tumor cell lines
Authors: Bertucci, F Van Hulst, S Bernard, K Loriod, B Granjeaud, S Tagett, R Starkey, M Nguyen, C Jordan, B Birnbaum, D
Citation: F. Bertucci et al., Expression scanning of an array of growth control genes in human tumor cell lines, ONCOGENE, 18(26), 1999, pp. 3905-3912
Expression profiling: DNA arrays in many guises
Authors: Granjeaud, S Bertucci, F Jordan, BR
Citation: S. Granjeaud et al., Expression profiling: DNA arrays in many guises, BIOESSAYS, 21(9), 1999, pp. 781-790
High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: Analysis of 67 patients treated in asingle institution
Authors: Bertucci, F Viens, P Gravis, G Blaise, D Faucher, C Oziel-Taoeb, S Bardou, VJ Jacquemier, J Delpero, JR Maraninchi, D
Citation: F. Bertucci et al., High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: Analysis of 67 patients treated in asingle institution, ANTICANC R, 19(2B), 1999, pp. 1455-1461
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy
Authors: Viens, P Jacquemier, J Bardou, VJ Bertucci, F Penault-Llorca, F Puig, B Gravis, G Oziel-Taieb, S Resbeut, M Houvenaeghel, G Camerlo, J Birbaum, D Hassoun, J Maraninchi, D
Citation: P. Viens et al., Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy, BREAST CANC, 54(3), 1999, pp. 205-212
Engagement of natural cytotoxicity programs regulates AP-1 expression in the NKL human NK cell line
Authors: Bernard, K Cambiaggi, A Guia, S Bertucci, F Granjeaud, S Tagett, R N'Guyen, C Jordan, BR Vivier, E
Citation: K. Bernard et al., Engagement of natural cytotoxicity programs regulates AP-1 expression in the NKL human NK cell line, J IMMUNOL, 162(7), 1999, pp. 4062-4068
Risultati: 1-17 |